Abstract
Gene therapy studies of cystic fibrosis (CF) have shown that AAV-based vector was efficient in transferring but not in expressing the CFTR cDNA in the target cells. The levels of CFTR gene expression were limited by the small packaging capacity of AAV because it had been difficult to package the CFTR cDNA with an efficient promoter. In the present study we have developed a new generation of AAV/CFTR vectors which contain efficient short promoters to express the CFTR gene in target cells. To do so, we reduced the size of the CFTR cDNA by determining the minimal untranslated regions required for expression of CFTR cDNA. We also identified short and efficient promoters that could be packaged with the down-sized CFTR cDNA into a novel AAV vector that had a maximal packag- ing capacity. Functional analyses showed that the new vectors were packaged efficiently and expressed higher levels of CFTR than a vector in which the CFTR gene was driven by the ITR sequence of AAV. Transduction of airway epithelial cells containing 508 mutation with the new vectors demonstrated efficient expression of the wild-type CFTR and correction of the CF phenotype. In contrast, no significant CFTR expression was detected in cells infected with the vector that express the CFTR gene from the ITR. These findings support the notion that the AAV can be developed into an efficient vector to transduce the CFTR gene and vectors expressing higher levels of CFTR from an efficient promoter should provide better efficacy for gene therapy of cystic fibrosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Riordan JR et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA Science 1989; 245: 1066–1073 and erratum Science 1989 245: 1437
Rommens JM et al. Identification of the cystic fibrosis gene: chromosome walking and jumping Science 1989 245: 1059–1065
Frizzell RA . Role of absorptive and secretory processes in hydration of the airway surface Am Rev Respir Dis 1988 138: S3–S6
Welsh MJ . Abnormal regulation of ion channels in cystic fibrosis epithelia FASEB J 1990 4: 2718–2725
Frizzell RA, Rechkemmer G, Shoemaker RL . Altered regulation of airway epithelial cell chloride channels in cystic fibrosis Science 1986 233: 558–560
Boat TF, Cheng PW . Epithelial cell dysfunction in cystic fibrosis: implications for airways disease Acta Paediatr Scand 1989 363 (Suppl): 25–29
Smith JJ, Travis SM, Greenberg EP, Welsh MJ . Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid Cell 1996; 85: 229–236 and erratum Cell 1996 87: 355
Collins FS . Cystic fibrosis: molecular biology and therapeutic implications Science 1992 256: 774–779
Fitzmorris S . Cystic Fibrosis Foundation Registry Data 1998
Drumm ML et al. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 1990; 62: 1227–1233 and erratum Cell 1993 74: 215
Rich DP et al. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells (see comments) Nature 1990 347: 358–363
Yoshimura K et al. Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer Nucleic Acids Res 1992 20: 3233–3240
Zabner J et al. Comparison of DNA–lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo J Clin Invest 1997 100: 1529–1537
Bout A et al. Lung gene therapy: in vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium Hum Gene Ther 1994 5: 3–10
Boucher RC et al. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill Hum Gene Ther 1994 5: 615–639
Crystal RG et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis (see comments) Nat Genet 1994 8: 42–51
Dong JY et al. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector Hum Gene Ther 1996 7: 319–331
Engelhardt JF et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study Hum Gene Ther 1993 4: 759–769
Crystal RG et al. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis Hum Gene Ther 1995 6: 667–703
Brody SL et al. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA Hum Gene Ther 1994 5: 821–836
Yang Y, Su Q, Wilson JM . Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs J Virol 1996 70: 7209–7212
Flotte TR et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector Proc Natl Acad Sci USA 1993 90: 10613–10617
Rubenstein RC et al. CFTR gene transduction in neonatal rabbits using an adeno-associated virus (AAV) vector Gene Therapy 1997 4: 384–392
Wagner JA et al. Efficient and persistent gene transfer of AAV-CFTR in the CF maxillary sinus Lancet 1998 351: 1702–1703
Flotte T . Adeno-associated virus (AAV) vectors: an update on AAV biology and Pulmonary and extra-pulmonary applications Pediatr Pulmonol 1997 14 (Suppl.): 83
Xiao X, Li J, Samulski RJ . Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J Virol 1996 70: 8098–8108
Fisher KJ et al. Recombinant adeno-associated virus for muscle directed gene therapy Nature Med 1997 3: 306–312
Clark KR, Sferra TJ, Johnson PR . Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle Hum Gene Ther 1997 8: 659–669
Flotte TR et al. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter J Biol Chem 1993 268: 3781–3790
Flotte T et al. A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease Hum Gene Ther 1996 7: 1145–1159
Dong JY, Fan PD, Frizzell RA . Quantitative analysis of the packaging capacity of recombinant adeno-associated virus Hum Gene Ther 1996 7: 2101–1112
Denome RM, Cole CN . Patterns of polyadenylation site selection in gene constructs containing multiple polyadenylation signals Mol Cell Biol 1988 8: 4829–4839
Heath CV, Denome RM, Cole CN . Spatial constraints on polyadenylation signal function J Biol Chem 1990 265: 9098–9104
Jefferson DM et al. Expression of normal and cystic fibrosis phenotypes by continuous airway epithelial cell lines Am J Physiol 1990 259: L496–505
Ruef C, Jefferson DM, Schlegel-Haueter SE, Suter S . Regulation of cytokine secretion by cystic fibrosis airway epithelial cells Eur Respir J 1993 6: 1429–1436
Widdicombe JH, Azizi F, Kang T, Pittet JF . Transient permeabilization of airway epithelium by mucosal water J Appl Physiol 1996 81: 491–499
Kunzelmann K et al. Culture-dependent expression of Na+ conductances in airway epithelial cells Pflugers Arch 1996 431: 578–586
Fan PD, Dong JY . Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV Hum Gene Ther 1997 8: 87–98
Samulski RJ, Chang LS, Shenk T . Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression J Virol 1989 63: 3822–3828
Fischer H, Illek B, Machen TE . The actin filament disrupter cytochalasin D activates the recombinant cystic fibrosis transmembrane conductance regulator Cl− channel in mouse 3T3 fibroblasts J Physiol 1995 489: 745–754
Laughlin CA, Tratschin JD, Coon H, Carter BJ . Cloning of infectious adeno-associated virus genomes in bacterial plasmids Gene 1983 23: 65–73
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, D., Fischer, H., Zhang, L. et al. Efficient CFTR expression from AAV vectors packaged with promoters – the second generation. Gene Ther 6, 667–675 (1999). https://doi.org/10.1038/sj.gt.3300856
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300856
Keywords
This article is cited by
-
Noninvasive optical activation of Flp recombinase for genetic manipulation in deep mouse brain regions
Nature Communications (2019)
-
The production of viral vectors designed to express large and difficult to express transgenes within neurons
Molecular Brain (2015)
-
Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons
Molecular Brain (2014)
-
Generation of Novel AAV Variants by Directed Evolution for Improved CFTR Delivery to Human Ciliated Airway Epithelium
Molecular Therapy (2009)
-
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes
Gene Therapy (2001)